Middle East & Africa Crispr-based Diagnostics Market Size & Outlook
MEA crispr-based diagnostics market highlights
- The MEA crispr-based diagnostics market generated a revenue of USD 72.4 million in 2024.
- The market is expected to grow at a CAGR of 14.9% from 2025 to 2030.
- In terms of segment, enzymes was the largest revenue generating product in 2024.
- Enzymes is the most lucrative product segment registering the fastest growth during the forecast period.
MEA data book summary
| Market revenue in 2024 | USD 72.4 million |
| Market revenue in 2030 | USD 163.0 million |
| Growth rate | 14.9% (CAGR from 2025 to 2030) |
| Largest segment | Enzymes |
| Fastest growing segment | Enzymes |
| Historical data covered | 2018 - 2023 |
| Base year for estimation | 2024 |
| Forecast period covered | 2025 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Enzymes |
Other key industry trends
- In terms of revenue, MEA region accounted for 2.3% of the global crispr-based diagnostics market in 2024.
- Globally, North America is projected to lead the regional market in terms of revenue in 2030.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 1,602.2 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
CRISPR-Based Diagnostics Market Scope
CRISPR-Based Diagnostics Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| ToolGen | View profile | 51-100 | Geumgok, Kyonggi-do, South Korea, Asia | http://www.toolgen.com |
| CrisprBits | View profile | 1-10 | Delhi, Delhi, India, Asia | https://crisprbits.com/ |
| Sherlock Biosciences | View profile | 51-100 | Cambridge, Massachusetts, United States, North America | https://sherlock.bio/ |
| Molbio Diagnostics | View profile | 1001-5000 | Verna, Goa, India, Asia | http://www.molbiodiagnostics.com |
| Thermo Fisher Scientific Inc. | View profile | - | - | - |
| Caribou Biosciences, Inc. | View profile | - | - | - |
| Integrated DNA Technologies | View profile | 501-1000 | Coralville, Iowa, United States, North America | http://idtdna.com |
| Mammoth Biosciences | View profile | 101-250 | San Francisco, California, United States, North America | https://mammoth.bio/ |
| Synthego | View profile | 251-500 | Redwood City, California, United States, North America | http://www.synthego.com |
| Horizon Discovery | View profile | 101-250 | Cambridge, Cambridgeshire, United Kingdom, Europe | http://www.horizondiscovery.com |
Middle East & Africa crispr-based diagnostics market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to crispr-based diagnostics market will help companies and investors design strategic landscapes.
Enzymes was the largest segment with a revenue share of 112.29% in 2024. Horizon Databook has segmented the Middle East & Africa crispr-based diagnostics market based on enzymes covering the revenue growth of each sub-segment from 2018 to 2030.
Reasons to subscribe to Middle East & Africa crispr-based diagnostics market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Middle East & Africa crispr-based diagnostics market databook
-
Our clientele includes a mix of crispr-based diagnostics market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the Middle East & Africa crispr-based diagnostics market , including forecasts for subscribers. This continent databook contains high-level insights into Middle East & Africa crispr-based diagnostics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Related industry reports
Related statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
